| ADMA BIOLOGICS, INC. |
Director |
Common Stock |
56,601 |
$255,837 |
$4.52 |
06 Mar 2023 |
Indirect |
| ADMA BIOLOGICS, INC. |
Director |
Employee Stock Option (right to buy) |
51,630 |
$188,966 |
$3.66 |
06 Mar 2023 |
Direct |
| Alpha Teknova, Inc. |
Director |
Common Stock |
12,000 |
$60,768 |
$5.06 |
27 Jun 2025 |
Direct |
| CHIMERIX INC |
Director |
Common Stock |
0 |
$0 |
$8.55 |
21 Apr 2025 |
By the Martha J. Demski Trust u/a 10/01/94 |
| Alpha Teknova, Inc. |
Director |
Non-Qualified Stock Option (right to buy) |
54,300 |
|
|
17 Jun 2025 |
Direct |
| Equillium, Inc. |
Director |
Director Stock Option (right to buy) |
20,000 |
|
|
21 May 2025 |
Direct |
| Equillium, Inc. |
Director |
Stock Option (right to buy) |
20,000 |
|
|
22 May 2024 |
Direct |
| Adamas Pharmaceuticals Inc |
Director |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
Direct |
| Adamas Pharmaceuticals Inc |
Director |
Common Stock |
0 |
|
$5.16 |
24 Nov 2021 |
Martha J. Demski U/D/T 10/1/1994, Martha J. Demski Trustee |
| Adamas Pharmaceuticals Inc |
Director |
Stock Option (Right to Buy) |
0 |
|
|
24 Nov 2021 |
Direct |
| CHIMERIX INC |
Director |
Employee Stock Option (Right to Buy) |
0 |
|
|
21 Apr 2025 |
Direct |